Liver enzymes in patients with chronic kidney disease undergoing peritoneal dialysis and hemodialysis

Detalhes bibliográficos
Autor(a) principal: Liberato, Isabella Ramos de Oliveira
Data de Publicação: 2012
Outros Autores: Lopes, Edmundo Pessoa de Almeida, Cavalcante, Maria Alina Gomes de Mattos, Pinto, Tiago Costa, Moura, Izolda Fernades, Loureiro Júnior, Luiz
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/19678
Resumo: OBJECTIVE: The present study was designed to analyze the serum levels of aspartate and alanine aminotransferases, gamma-glutamyl transferase, and the hematocrit in patients with chronic kidney disease who were undergoing peritoneal dialysis or hemodialysis. PATIENTS AND METHODS: Twenty patients on peritoneal dialysis and 40 on hemodialysis were assessed, and the patients were matched according to the length of time that they had been on dialysis. Blood samples were collected (both before and after the session for those on hemodialysis) to measure the enzymes and the hematocrit. RESULTS: In the samples from the patients who were undergoing peritoneal dialysis, the aspartate and alanine aminotransferase levels were slightly higher compared with the samples collected from the patients before the hemodialysis session and slightly lower compared with the samples collected after the hemodialysis session. The levels of gamma-glutamyl transferase in the hemodialysis patients were slightly higher than the levels in the patients who were undergoing peritoneal dialysis. In addition, the levels of aminotransferases and gamma-glutamyl transferase that were collected before the hemodialysis session were significantly lower than the values collected after the session. The hematocrit levels were significantly lower in the patients who were on peritoneal dialysis compared with the patients on hemodialysis (both before and after the hemodialysis session), and the levels were also significantly lower before hemodialysis compared with after hemodialysis. CONCLUSION: The aminotransferase levels in the patients who were undergoing peritoneal dialysis were slightly higher compared with the samples collected before the hemodialysis session, whereas the aminotransferase levels were slightly lower compared with the samples collected after the session. The hematocrits and the aminotransferase and gamma-glutamyl transferase levels of the samples collected after the hemodialysis session were significantly higher than the samples collected before the session. Taken together, the present data suggest that hemodilution could alter the serum levels of liver enzymes.
id USP-19_3d7ff7fabf93f0e002268ea9fb0f4836
oai_identifier_str oai:revistas.usp.br:article/19678
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Liver enzymes in patients with chronic kidney disease undergoing peritoneal dialysis and hemodialysisAlanine aminotransferaseLiver enzymesHemodialysisPeritoneal dialysisChronic renal failureOBJECTIVE: The present study was designed to analyze the serum levels of aspartate and alanine aminotransferases, gamma-glutamyl transferase, and the hematocrit in patients with chronic kidney disease who were undergoing peritoneal dialysis or hemodialysis. PATIENTS AND METHODS: Twenty patients on peritoneal dialysis and 40 on hemodialysis were assessed, and the patients were matched according to the length of time that they had been on dialysis. Blood samples were collected (both before and after the session for those on hemodialysis) to measure the enzymes and the hematocrit. RESULTS: In the samples from the patients who were undergoing peritoneal dialysis, the aspartate and alanine aminotransferase levels were slightly higher compared with the samples collected from the patients before the hemodialysis session and slightly lower compared with the samples collected after the hemodialysis session. The levels of gamma-glutamyl transferase in the hemodialysis patients were slightly higher than the levels in the patients who were undergoing peritoneal dialysis. In addition, the levels of aminotransferases and gamma-glutamyl transferase that were collected before the hemodialysis session were significantly lower than the values collected after the session. The hematocrit levels were significantly lower in the patients who were on peritoneal dialysis compared with the patients on hemodialysis (both before and after the hemodialysis session), and the levels were also significantly lower before hemodialysis compared with after hemodialysis. CONCLUSION: The aminotransferase levels in the patients who were undergoing peritoneal dialysis were slightly higher compared with the samples collected before the hemodialysis session, whereas the aminotransferase levels were slightly lower compared with the samples collected after the session. The hematocrits and the aminotransferase and gamma-glutamyl transferase levels of the samples collected after the hemodialysis session were significantly higher than the samples collected before the session. Taken together, the present data suggest that hemodilution could alter the serum levels of liver enzymes.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2012-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1967810.6061/clinics/2012(02)07Clinics; Vol. 67 No. 2 (2012); 131-134Clinics; v. 67 n. 2 (2012); 131-134Clinics; Vol. 67 Núm. 2 (2012); 131-1341980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/19678/21742Liberato, Isabella Ramos de OliveiraLopes, Edmundo Pessoa de AlmeidaCavalcante, Maria Alina Gomes de MattosPinto, Tiago CostaMoura, Izolda FernadesLoureiro Júnior, Luizinfo:eu-repo/semantics/openAccess2012-05-24T18:50:37Zoai:revistas.usp.br:article/19678Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-24T18:50:37Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Liver enzymes in patients with chronic kidney disease undergoing peritoneal dialysis and hemodialysis
title Liver enzymes in patients with chronic kidney disease undergoing peritoneal dialysis and hemodialysis
spellingShingle Liver enzymes in patients with chronic kidney disease undergoing peritoneal dialysis and hemodialysis
Liberato, Isabella Ramos de Oliveira
Alanine aminotransferase
Liver enzymes
Hemodialysis
Peritoneal dialysis
Chronic renal failure
title_short Liver enzymes in patients with chronic kidney disease undergoing peritoneal dialysis and hemodialysis
title_full Liver enzymes in patients with chronic kidney disease undergoing peritoneal dialysis and hemodialysis
title_fullStr Liver enzymes in patients with chronic kidney disease undergoing peritoneal dialysis and hemodialysis
title_full_unstemmed Liver enzymes in patients with chronic kidney disease undergoing peritoneal dialysis and hemodialysis
title_sort Liver enzymes in patients with chronic kidney disease undergoing peritoneal dialysis and hemodialysis
author Liberato, Isabella Ramos de Oliveira
author_facet Liberato, Isabella Ramos de Oliveira
Lopes, Edmundo Pessoa de Almeida
Cavalcante, Maria Alina Gomes de Mattos
Pinto, Tiago Costa
Moura, Izolda Fernades
Loureiro Júnior, Luiz
author_role author
author2 Lopes, Edmundo Pessoa de Almeida
Cavalcante, Maria Alina Gomes de Mattos
Pinto, Tiago Costa
Moura, Izolda Fernades
Loureiro Júnior, Luiz
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Liberato, Isabella Ramos de Oliveira
Lopes, Edmundo Pessoa de Almeida
Cavalcante, Maria Alina Gomes de Mattos
Pinto, Tiago Costa
Moura, Izolda Fernades
Loureiro Júnior, Luiz
dc.subject.por.fl_str_mv Alanine aminotransferase
Liver enzymes
Hemodialysis
Peritoneal dialysis
Chronic renal failure
topic Alanine aminotransferase
Liver enzymes
Hemodialysis
Peritoneal dialysis
Chronic renal failure
description OBJECTIVE: The present study was designed to analyze the serum levels of aspartate and alanine aminotransferases, gamma-glutamyl transferase, and the hematocrit in patients with chronic kidney disease who were undergoing peritoneal dialysis or hemodialysis. PATIENTS AND METHODS: Twenty patients on peritoneal dialysis and 40 on hemodialysis were assessed, and the patients were matched according to the length of time that they had been on dialysis. Blood samples were collected (both before and after the session for those on hemodialysis) to measure the enzymes and the hematocrit. RESULTS: In the samples from the patients who were undergoing peritoneal dialysis, the aspartate and alanine aminotransferase levels were slightly higher compared with the samples collected from the patients before the hemodialysis session and slightly lower compared with the samples collected after the hemodialysis session. The levels of gamma-glutamyl transferase in the hemodialysis patients were slightly higher than the levels in the patients who were undergoing peritoneal dialysis. In addition, the levels of aminotransferases and gamma-glutamyl transferase that were collected before the hemodialysis session were significantly lower than the values collected after the session. The hematocrit levels were significantly lower in the patients who were on peritoneal dialysis compared with the patients on hemodialysis (both before and after the hemodialysis session), and the levels were also significantly lower before hemodialysis compared with after hemodialysis. CONCLUSION: The aminotransferase levels in the patients who were undergoing peritoneal dialysis were slightly higher compared with the samples collected before the hemodialysis session, whereas the aminotransferase levels were slightly lower compared with the samples collected after the session. The hematocrits and the aminotransferase and gamma-glutamyl transferase levels of the samples collected after the hemodialysis session were significantly higher than the samples collected before the session. Taken together, the present data suggest that hemodilution could alter the serum levels of liver enzymes.
publishDate 2012
dc.date.none.fl_str_mv 2012-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/19678
10.6061/clinics/2012(02)07
url https://www.revistas.usp.br/clinics/article/view/19678
identifier_str_mv 10.6061/clinics/2012(02)07
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/19678/21742
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 67 No. 2 (2012); 131-134
Clinics; v. 67 n. 2 (2012); 131-134
Clinics; Vol. 67 Núm. 2 (2012); 131-134
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222758238420992